CNCCentene Corporation
AI adoption · Q1 2026 earnings call
Health CarePiloting
2
extracted from this call
3 / 5
operational, no hard numbers
Not disclosed
no breakout in this call
AI was mentioned only once on this call, briefly by CFO Drew Asher in prepared remarks, describing the deployment of 'AI-enabled tools' across forecasting, medical economics, and payment integrity functions. The commentary was operational in nature but lacked quantification of cost savings, productivity gains, or investment levels. AI was framed as an internal productivity and fraud-detection tool, not a product or revenue driver.
Adopter
See full leaderboard →27/ 100
51
stage: piloting · max spec: 3
0
no quantified disclosure
35
1 scope
internal_use
2 AI mentions from this call.
Extracted verbatim from the CNC Q1 2026 earnings call transcript. Speaker, section, and specificity tier surfaced for each mention.
- T3Prepared remarks· CFO· Internal use
“within finance, we are deploying advanced analytics and selective AI-enabled tools across forecasting, medical economics and payment integrity. Today, these capabilities are used as an independent validation layer alongside our traditional forecasting process, bringing more timely data into how we evaluate emerging medical trend. Also helping us identify fraud, waste and abnormal claims behavior earlier, supporting better prioritization of resources and more disciplined cost management on behalf of state and federal tax payers.”
— Andrew Asher, CNC earnings call - T3Q&A· CEO· Internal useI wanted to come back to the fraud, waste and abuse topic, and a follow-up to George's question.
“Drew talked about that in his remarks as well in terms of where we're deploying AI and some of those daily algorithms that we run.”
— Sarah London, CNC earnings call
What management wouldn’t quantify.
Analyst questions where management declined to share a specific number. The pattern of refusals is often as informative as the disclosures.
- No quantification of AI investment (capex or opex) provided.
- No productivity metrics, cost savings, or headcount impact attributed to AI tools disclosed.
- No detail on which specific AI vendors, models, or platforms are being used.
- No disclosure of the scale of deployment (number of users, markets, or workflows covered).
- CFO mentioned AI in passing without any follow-up analyst questions on the topic; no analyst pressed for further detail.
Compare with peers.
Other companies in the same sector and at the same AI adoption stage.
Same GICS sector, all stages
Independent research, direct to your inbox.
Live data tracking and analysis. Deep research that cuts through consensus. Evidence-backed insights.